+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
Anacetrapib (CAS 875446-37-0) Global Market Research Report 2024 - Product Thumbnail Image

Anacetrapib (CAS 875446-37-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Aprindine (CAS 37640-71-4) Global Market Research Report 2024 - Product Thumbnail Image

Aprindine (CAS 37640-71-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Barnidipine (CAS 104713-75-9) Global Market Research Report 2024 - Product Thumbnail Image

Barnidipine (CAS 104713-75-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Aminometradine (CAS 642-44-4) Global Market Research Report 2024 - Product Thumbnail Image

Aminometradine (CAS 642-44-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Benziodarone (CAS 68-90-6) Global Market Research Report 2024 - Product Thumbnail Image

Benziodarone (CAS 68-90-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Aliskiren (CAS 173334-57-1) Global Market Research Report 2024 - Product Thumbnail Image

Aliskiren (CAS 173334-57-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Alacepril (CAS 74258-86-9) Global Market Research Report 2024 - Product Thumbnail Image

Alacepril (CAS 74258-86-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Eprosartan (CAS 133040-01-4) Global Market Research Report 2024 - Product Thumbnail Image

Eprosartan (CAS 133040-01-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Dopexamine (CAS 86197-47-9) Global Market Research Report 2024 - Product Thumbnail Image

Dopexamine (CAS 86197-47-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Disopyramide (CAS 3737-09-5) Global Market Research Report 2024 - Product Thumbnail Image

Disopyramide (CAS 3737-09-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Etofibrate (CAS 31637-97-5) Global Market Research Report 2024 - Product Thumbnail Image

Etofibrate (CAS 31637-97-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Esculin (CAS 531-75-9) Global Market Research Report 2024 - Product Thumbnail Image

Esculin (CAS 531-75-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Etafenone (CAS 90-54-0) Global Market Research Report 2024 - Product Thumbnail Image

Etafenone (CAS 90-54-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Dimetofrine (CAS 22950-29-4) Global Market Research Report 2024 - Product Thumbnail Image

Dimetofrine (CAS 22950-29-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Enoximone (CAS 77671-31-9) Global Market Research Report 2024 - Product Thumbnail Image

Enoximone (CAS 77671-31-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Darapladib (CAS 356057-34-6) Global Market Research Report 2024 - Product Thumbnail Image

Darapladib (CAS 356057-34-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more